Product News and Recalls

Psoriasis Drug Linked to Brain Infection and Death

Raptiva is an injectable drug used for the treatment of psoriasis.  It has been discovered to cause a serious brain infection called progressive multifocal leukoencephalopathy, or PML. The FDA has confirmed at least three cases of patients who died from PML after using Raptiva more than three years.  According to the National Institutes of Health, PML usually lasts for months, 80 percent die within the first six months, and those who survive can be left with severe neurological disabilities.

In October ...

continue reading...

Anti-Parkinson’s Drug Leads to Compulsive Behavior

FEBRUARY 17, 2009 – Requip, a drug designed to treat Parkinson’s Disease and also sold as a treatment for Restless Leg Syndrome, has been linked to compulsive behaviors, including gambling. This is similar to the effects of the drug Mirapex, another dopamine agonist for treating Parkinson’s. As early as 2003, these drugs were known to cause pathological gambling and other compulsive behavior.

continue reading...

Aftershocks From Vioxx Verdict: Legal and Financial Experts Watching the Case Saw the Ruling Either as a Texas Anomaly or a Dire Warning to Merck

By Josh Goldstein and Joseph N. DiStefano

August 20, 2005

The Philadelphia Inquirer

It was just the first of more than 4,200 lawsuits against Merck & Co. Inc. over its Vioxx painkiller, but news of yesterday’s $253.4 million verdict in Texas against the drugmaker surged through the legal profession and Wall Street.

In New York City, where Alise Reicin, Merck’s vice president of clinical research, was being deposed by lawyers representing plaintiffs in other Vioxx cases, the verdict caused a stir.

Shortly after learning the ...

continue reading...

Suits Over Antiobiotic Ketek Bolstered by House Inquiry Into Faulty Testing

By Maria Vogel-Short

New Jersey Law Journal

February 13, 2008

Plaintiffs in New Jersey and six other states who claim the antibiotic Ketek caused liver disease are getting a booster shot from a congressional inquiry into the clinical trials that led to FDA approval.

On Tuesday, witnesses at a hearing before the House Committee on Energy and Commerce’s Subcommittee on Oversight and Investigations testified that Ketek’s trials were flawed and that the company had knowledge of flawed data even before FDA approval.

More than pending ...

continue reading...

Cedars-Sinai Patients Affected by Disease

FOR IMMEDIATE RELEASE:

CONTACT: Attorney Ramon R. Lopez and/or Attorney Jason E. Ochs
Telephone: 949-737-1501
Fax: 949-737-1504
Email: rlopez@lopezmchugh.com, jochs@lopezmchugh.com

CEDARS-SINAI PATIENTS SUE BECAUSE OF FATAL DISEASE.
Los Angeles, California, January 16, 2008 – On Friday, January 11, 2008, 63-year-old Priscilla Geffen and 60-year-old Michael Gleaton filed nearly identical lawsuits alleging that they contracted a rare, terminal disease known as nephrogenic systemic fibrosis after undergoing routine MRI’s with gadolinium-contrast dye at the S. Mark Taper Imaging Center ...

continue reading...

The engineer responsible for the Metrolink commuter train crash was known to improperly use his cell phone while on duty

The only surviving crew member of the Metrolink commuter train disaster told federal investigators that a few months before the collision, he had previously complained to a supervisor about the engineer’s improper use of his cell phone while on duty. The head-on collision with a freight train resulted in 25 people dead and 135 injured when the engineer failed to stop at a red light.

A mere two days before the collision, the crew member had asked the same supervisor whether ...

continue reading...
Page 299 of 305 «...270280290297298299300301...»